TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD: institutional ownership and insider trading
96 funds reported holding $218M of TEVA PHARMACEUTICAL INDUSTRIES LTD in their latest 13F filings; in Q4 2025 funds net bought $0, with 0 new positions and 1 funds selling out; over the last 12 months insiders bought $0 and sold $113M on the open market; over its last four quarters it reported revenue of $14.1B and net income of $707M.
TEVA revenue and earnings
- Quarter ended Jun 30, 2026: revenue $4.14B, net income −$576M, EPS -0.49
- Quarter ended Mar 31, 2026: revenue $3.98B, net income $369M, EPS 0.31
- Quarter ended Dec 31, 2025: revenue $1.50B, net income $481M, EPS 0.42
- Quarter ended Sep 30, 2025: revenue $4.48B, net income $433M, EPS 0.37
Largest institutional holders of TEVA
- Assenagon Asset Management S.A. — $55.4M
- Vontobel Holding Ltd. — $17.0M
- Hennion & Walsh Asset Management, Inc. — $13.8M
- BOURGEON CAPITAL MANAGEMENT LLC — $12.9M
- IFM Investors Pty Ltd — $10.8M
- CONTINENTAL ADVISORS LLC — $10.6M
- Y-Intercept (Hong Kong) Ltd — $10.2M
- Sterling Capital Management LLC — $6.99M
- Burford Brothers, Inc. — $5.80M
- IFP Advisors, Inc — $5.70M
Recent TEVA insider trades
- Sep 18, 2026: Mignone Roberto sold 367,600 shares ($14.4M)
- Sep 18, 2026: Savage Brian sold 7,342 shares ($285K)
- Aug 21, 2026: Satchi-Fainaro Ronit sold 415 shares ($15.5K)
- Aug 21, 2026: Weiss Amir sold 9,445 shares ($355K)
5%+ owners
- Harel Insurance Investments & Financial Services Ltd: 6.3% (Schedule 13G/A, filed Feb 9, 2026)
- Migdal Insurance & Financial Holdings Ltd: 5.4% (Schedule 13G, filed Feb 17, 2026)
- Phoenix Financial Ltd.: 5.0% (Schedule 13G, filed Jul 22, 2025)
- Menora Mivtachim Holdings Ltd: 5.0% (Schedule 13G, filed Jul 17, 2025)
Who owns the most TEVA stock?
The largest institutional holders of TEVA PHARMACEUTICAL INDUSTRIES LTD in the latest 13F filings are Assenagon Asset Management S.A. ($55.4M), Vontobel Holding Ltd. ($17.0M), Hennion & Walsh Asset Management, Inc. ($13.8M).
Are insiders buying or selling TEVA?
Over the last 12 months insiders bought $0 and sold $113M of TEVA PHARMACEUTICAL INDUSTRIES LTD stock on the open market (SEC Form 4).
What was TEVA's revenue last quarter?
TEVA PHARMACEUTICAL INDUSTRIES LTD reported revenue of $4.14B for the quarter ended June 30, 2026, with net income of −$576M.